Evidence map›Paper›PMID 40306939›Full record

Trial reportBMJ mental health2025

Preventing suicide with Safe Alternatives for Teens and Youths (SAFETY): a randomised feasibility trial.

Moa Karemyr, Martin Bellander, Moa Pontén, Anna Ohlis, Oskar Flygare, Ylva Walldén, Ralf Kuja-Halkola, Gergö Hadlaczky, David Mataix-Cols, Joan Rosenbaum Asarnow and 3 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05537623 (Preventing Suicide With Safe Alternatives for Teens and Youths), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05537623 nacompletednot on this map

Preventing Suicide With Safe Alternatives for Teens and Youths (SAFETY) - A Randomized Controlled Feasibility Trial

TypeinterventionalSponsorRegion StockholmRan2022 to 2025Enrolled30ConditionsSuicide and Self-harmArmsSafe Alternatives for Teens and Youths (SAFETY), Supportive Therapy
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Moa KaremyrDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden moa.karemyr@ki.se.ORCID 0009-0006-1264-7663
Martin BellanderDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-0377-4979
Moa PonténDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-2407-0412
Anna OhlisDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Oskar FlygareDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-2017-3940
Ylva WalldénDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Ralf Kuja-HalkolaDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-3765-2067
Gergö HadlaczkyDepartment of Learning Management and Ethics, Karolinska Institutet, Stockholm, Sweden.
David Mataix-ColsDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Joan Rosenbaum AsarnowDepartment of Psychiatry, University of California Los Angeles, Los Angeles, California, USA.
Clara HellnerDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Jennifer L HughesDepartment of Psychiatry and Behavioral Health, College of Medicine, and Division of Health Behavior and Health Promotion, College of Public Health, The Ohio State University, Columbus, Ohio, USA.
Johan BjurebergDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-2747-9990

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSuicide attempts are common in youth and have potentially lethal outcomes. Effective treatments targeting suicide attempts are scarce.

objectiveTo assess the feasibility and preliminary efficacy of a family-based cognitive behavioural treatment relative to an active control for youth with suicidal behaviour.

methods30 youths (93% female; mean (SD) age=14.6 (1.5) years) residing in Sweden with recent suicidal behaviour (last 3 months) and at least one available parent were randomised to 12 weeks of the family-based cognitive behavioural treatment Safe Alternatives for Teens and Youths (SAFETY) or supportive therapy, an active control treatment. Primary endpoint was 3-month post-treatment. Feasibility outcomes included treatment and assessment compliance, adverse events, treatment credibility and treatment satisfaction. Secondary outcomes included suicide attempt, non-suicidal self-injury, anxiety, depression, quality of life and emotion dysregulation.

findingsBoth treatments showed high compliance, satisfaction, credibility and session completion, with few adverse events and dropouts as well as low attrition (7% at primary endpoint). At the primary endpoint, two (14%) participants in SAFETY and four (27%) in supportive therapy had attempted suicide. Non-suicidal self-injury was reduced by 95% (incidence rate ratio=0.05 (95% CI 0.01 to 0.20)) in SAFETY and 69% (incidence rate ratio=0.31 (0.11 to 0.83)) in supportive therapy. Participation in SAFETY, but not in supportive therapy, was associated with moderate-to-large within-group improvements in anxiety and depression (Cohen's d=0.85 [0.33 to 1.40]), quality of life (d

conclusionsThe results suggest that SAFETY is feasible and promising for youth with suicidal behaviour. CLINICAL IMPLICATIONS: A large randomised controlled trial is warranted to further examine the efficacy of SAFETY. TRIAL REGISTRATION NUMBER: NCT05537623.

Indexed as

Cognitive Behavioral TherapyFamily TherapySuicide PreventionAdolescentFeasibility StudiesFemaleHumansMalePatient SatisfactionSelf-Injurious BehaviorSuicide, AttemptedSwedenChild & adolescent psychiatrySuicide & self-harm

Identifiers

PMID40306939
PMCPMC12049871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.